These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8314977)

  • 1. Pregnancy following GnRH agonist therapy of uterine leiomyoma obstructing a single fallopian tube.
    Ben-Ami M; Battino S; Shalev E
    Hum Reprod; 1993 May; 8(5):780-1. PubMed ID: 8314977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of uterine myoma with long-acting gonadotropin-releasing hormone agonist prior to myomectomy.
    Liu CH; Lin YS; Lin CC; Tzeng CC; Chou CY
    J Formos Med Assoc; 1993 Jun; 92(6):536-9. PubMed ID: 8106041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
    Kessel B; Liu J; Mortola J; Berga S; Yen SS
    Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolapsed leiomyoma with severe haemorrhage after GnRH analogue therapy.
    Kriplani A; Agarwal N; Parul D; Bhatla N; Saxena AK
    J Obstet Gynaecol; 2002 Jul; 22(4):449-51. PubMed ID: 12521484
    [No Abstract]   [Full Text] [Related]  

  • 6. Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy.
    Broekmans FJ; Hompes PG; Heitbrink MA; Netelenbos CC; Roos JC; Falke TM; Schoemaker J
    Am J Obstet Gynecol; 1996 Nov; 175(5):1208-16. PubMed ID: 8942490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: a case report and literature review.
    Milman D; Zalel Y; Biran H; Open M; Caspi B; Hagay Z; Dgani R
    Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):237-40. PubMed ID: 9481582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological changes of uterine leiomyomas after GnRH agonist therapy.
    Grigoriadis C; Papaconstantinou E; Mellou A; Hassiakos D; Liapis A; Kondi-Pafiti A
    Clin Exp Obstet Gynecol; 2012; 39(2):191-4. PubMed ID: 22905461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent ectopic pregnancy following in-vitro fertilization.
    al-Hussaini T; Mettler L
    Hum Reprod; 1992 Nov; 7(10):1479-80. PubMed ID: 1291581
    [No Abstract]   [Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma.
    Higashijima T; Kataoka A; Nishida T; Yakushiji M
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):169-73. PubMed ID: 8886702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of triptorelin in the medical treatment of uterine myoma].
    Palagiano A; Trotta C; Izzo A; Ragucci N
    Minerva Ginecol; 1993 Apr; 45(4):171-5. PubMed ID: 8506066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response.
    Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J
    Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy following regression of uterine submucosal leiomyoma with GnRH therapy; a case report.
    Volpe A; Adamo R; Coukos G; Silferi M; Artini PG; Genazzani AR
    Eur J Obstet Gynecol Reprod Biol; 1991 May; 39(3):223-5. PubMed ID: 1903347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist.
    Huang SC; Chou CY; Lin YS; Tsai YC; Hsu KF; Liu CH; Huang KE
    Am J Obstet Gynecol; 1997 Aug; 177(2):417-24. PubMed ID: 9290461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment.
    Ito F; Kawamura N; Ichimura T; Tsujimura A; Ishiko O; Ogita S
    Fertil Steril; 2001 Jan; 75(1):125-30. PubMed ID: 11163826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
    Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium.
    van de Ven J; Donker TH; Blankenstein MA; Thijssen JH
    Fertil Steril; 2002 Jun; 77(6):1227-32. PubMed ID: 12057733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
    Filicori M; Hall DA; Loughlin JS; Rivier J; Vale W; Crowley WF
    Am J Obstet Gynecol; 1983 Nov; 147(6):726-7. PubMed ID: 6356927
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
    Mizutani T; Sugihara A; Nakamuro K; Terada N
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
    Takahashi K; Kawamura N; Ishiko O; Ogita S
    Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.